Chemours Company [CC] stock is trading at $23.89, up 1.70%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CC shares have lost -0.99% over the last week, with a monthly amount glided 4.51%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Chemours Company [NYSE: CC] stock has seen the most recent analyst activity on July 09, 2024, when UBS upgraded its rating to a Buy and also boosted its price target to $30 from $28. Previously, Mizuho started tracking the stock with Neutral rating on June 07, 2024, and set its price target to $25. On April 09, 2024, upgrade upgraded it’s rating to Outperform and revised its price target to $34 on the stock. UBS downgraded its rating to a Neutral and decreased its price target to $21 on March 05, 2024. BMO Capital Markets downgraded its rating to a Underperform and reduced its price target to $19 on February 29, 2024. RBC Capital Mkts upgraded its rating to Outperform for this stock on December 01, 2023, and upped its price target to $40. In a note dated June 22, 2023, BofA Securities downgraded an Neutral rating on this stock and revised its target price from $41 to $37.
Chemours Company [CC] stock has fluctuated between $15.10 and $38.80 over the past year. Currently, Wall Street analysts expect the stock to reach $31.89 within the next 12 months. Chemours Company [NYSE: CC] shares were valued at $23.89 at the most recent close of the market. An investor can expect a potential return of 33.49% based on the average CC price forecast.
Analyzing the CC fundamentals
Chemours Company [NYSE:CC] reported sales of 5.84B for the trailing twelve months, which represents a drop of -12.11%. Gross Profit Margin for this corporation currently stands at 0.21% with Operating Profit Margin at -0.03%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.43 and Total Capital is -0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 5.66.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 23.36 points at the first support level, and at 22.82 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.18, and for the 2nd resistance point, it is at 24.46.
Ratios To Look Out For
For context, Chemours Company’s Current Ratio is 1.61. Further, the Quick Ratio stands at 0.99, while the Cash Ratio is 0.33. Considering the valuation of this stock, the price to sales ratio is 0.61, the price to book ratio is 4.73.
